Azithromycin for the Prevention of COPD Exacerbations: The Good, Bad, and Ugly

被引:40
作者
Taylor, Stephanie Parks [1 ]
Sellers, Eric [2 ]
Taylor, Brice T. [3 ]
机构
[1] Carolinas Med Ctr, Dept Internal Med, Charlotte, NC 28203 USA
[2] Med Univ S Carolina, Dept Internal Med, Charleston, SC USA
[3] Carolinas Med Ctr, Dept Internal Med, Div Pulm & Crit Care, Charlotte, NC 28203 USA
关键词
Azithromycin; COPD exacerbation; Macrolide; QT prolongation; OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; BRONCHIOLITIS OBLITERANS SYNDROME; CYSTIC FIBROSIS BRONCHIECTASIS; LONG-TERM AZITHROMYCIN; TORSADES-DE-POINTES; PSEUDOMONAS-AERUGINOSA; CARDIOVASCULAR EVENTS; MAINTENANCE TREATMENT; DOUBLE-BLIND;
D O I
10.1016/j.amjmed.2015.07.032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Long-term azithromycin therapy has been shown to reduce exacerbations of chronic obstructive pulmonary disease (COPD), and is recommended by recent society guidelines for use in COPD patients who are at risk for recurrent exacerbations. However, concerns about adverse effects have limited its widespread adoption. Physicians deciding whether to use long-term azithromycin therapy must weigh each patient's individual risk of cardiovascular complications and both the individual and population impact of macrolide resistance against the expected benefit. This review will summarize evidence on the effectiveness and safety of chronic azithromycin for the prevention of COPD exacerbations. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:1362.e1 / 1362.e6
页数:6
相关论文
共 56 条
[1]   Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation [J].
Aaron, SD ;
Vandemheen, KL ;
Clinch, JJ ;
Ahuja, J ;
Brison, RJ ;
Dickinson, G ;
Hébert, PC .
CHEST, 2002, 121 (03) :688-696
[2]   Inhaled Corticosteroids vs Placebo for Preventing COPD Exacerbations A Systematic Review and Metaregression of Randomized Controlled Trials [J].
Agarwal, Ritesh ;
Aggarwal, Ashutosh N. ;
Gupta, Dheeraj ;
Jindal, Surinder K. .
CHEST, 2010, 137 (02) :318-325
[3]   Azithromycin for Prevention of Exacerbations of COPD [J].
Albert, Richard K. ;
Connett, John ;
Bailey, William C. ;
Casaburi, Richard ;
Cooper, J. Allen D., Jr. ;
Criner, Gerard J. ;
Curtis, Jeffrey L. ;
Dransfield, Mark T. ;
Han, MeiLan K. ;
Lazarus, Stephen C. ;
Make, Barry ;
Marchetti, Nathaniel ;
Martinez, Fernando J. ;
Madinger, Nancy E. ;
McEvoy, Charlene ;
Niewoehner, Dennis E. ;
Porsasz, Janos ;
Price, Connie S. ;
Reilly, John ;
Scanlon, Paul D. ;
Sciurba, Frank C. ;
Scharf, Steven M. ;
Washko, George R. ;
Woodruff, Prescott G. ;
Anthonisen, Nicholas R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (08) :689-698
[4]   Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations Among Patients With Non-Cystic Fibrosis Bronchiectasis The BAT Randomized Controlled Trial [J].
Altenburg, Josje ;
de Graaff, Casper S. ;
Stienstra, Ymkje ;
Sloos, Jacobus H. ;
van Haren, Eric H. J. ;
Koppers, Ralph J. H. ;
van der Werf, Tjip S. ;
Boersma, Wim G. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (12) :1251-1259
[5]  
[Anonymous], 2015, GLOBAL STRATEGY DIAG
[6]   ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
ANTHONISEN, NR ;
MANFREDA, J ;
WARREN, CPW ;
HERSHFIELD, ES ;
HARDING, GKM ;
NELSON, NA .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :196-204
[7]   Role of long term antibiotics in chronic respiratory diseases [J].
Babu, K. Suresh ;
Kastelik, J. ;
Morjaria, J. B. .
RESPIRATORY MEDICINE, 2013, 107 (06) :800-815
[8]   The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD [J].
Banerjee, D ;
Khair, OA ;
Honeybourne, D .
RESPIRATORY MEDICINE, 2005, 99 (02) :208-215
[9]   Cardiovascular events in patients with COPD: TORCH Study results [J].
Calverley, Peter M. A. ;
Anderson, Julie A. ;
Celli, Bartolome ;
Ferguson, Gary T. ;
Jenkins, Christine ;
Jones, Paul W. ;
Crim, Courtney ;
Willits, Lisa R. ;
Yates, Julie C. ;
Vestbo, Jorgen .
THORAX, 2010, 65 (08) :719-725
[10]   Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments [J].
Cameron, E. J. ;
McSharry, C. ;
Chaudhuri, R. ;
Farrow, S. ;
Thomson, N. C. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2012, 42 (09) :1302-1312